Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
Insights
Blogs
Sharing perspectives leads to greater understanding and fuels innovation

Check out our latest blog posts:
![]() |
May 02, 2023 · Clinical Team
On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan® (naloxone hydrochloride) 4 mg Nasal Spray for over-the-counter (OTC), nonprescription, use. Read more... |
![]() |
May 01, 2023 · Clinical Team
Akorn Operating Company LLC filed Chapter 7 bankruptcy and the company has ceased all operations, including the discontinuation of the quality activities of these marketed drug products. Read more... |
![]() |
April 20, 2023 · Clinical Team
On April 21, 2023, the ODG Drug Formulary (Appendix A) status will change for several medications within the topical analgesic and nonsteroidal anti-inflammatory (NSAID) classes. Read more... |
![]() |
April 14, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on policy developments across the country, including Oregon workers’ comp updated rules, and Virginia workers’ comp cancer presumption and anxiety disorder bills. Read more... |
![]() |
April 06, 2023 · Clinical Team
Our Brand–Generic Pipeline lists new medications approved by the U.S. FDA and first-time generics or brand alternatives that potentially may be prescribed for the treatment of a workers’ compensation or auto injury. The Brand–Generic Pipeline for Q1 2023 is now available -- read it here. Read more... |
![]() |
March 22, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on Alabama workers’ compensation fee schedule, physician choice legislation in Montana and Iowa, and New York considering halting pharmacy direction of care. Read more... |
![]() |
March 01, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on CA medical provider networks and utilization review, CO 10th annual stakeholder meetings, CT pharmacy treatment notifications, NY pharmacy direction of care, and policy developments in NJ and ND. Read more... |
![]() |
February 08, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
![]() |
January 19, 2023 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
![]() |
December 07, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
![]() |
November 16, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
![]() |
October 26, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
Page 5 of 7